Matthew Perri

1.7k total citations
64 papers, 1.4k citations indexed

About

Matthew Perri is a scholar working on Pharmacology, Economics and Econometrics and Geriatrics and Gerontology. According to data from OpenAlex, Matthew Perri has authored 64 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 19 papers in Economics and Econometrics and 17 papers in Geriatrics and Gerontology. Recurrent topics in Matthew Perri's work include Pharmaceutical industry and healthcare (23 papers), Pharmaceutical Practices and Patient Outcomes (17 papers) and Pharmaceutical Economics and Policy (10 papers). Matthew Perri is often cited by papers focused on Pharmaceutical industry and healthcare (23 papers), Pharmaceutical Practices and Patient Outcomes (17 papers) and Pharmaceutical Economics and Policy (10 papers). Matthew Perri collaborates with scholars based in United States, Trinidad and Tobago and Jamaica. Matthew Perri's co-authors include Ajit M. Menon, Aparna Deshpande, Christopher L. Cook, George M. Zinkhan, Jung Sun Lee, Elisabeth Lilian Pia Sattler, Jack E. Fincham, Alex Z. Fu, Bradley C. Martin and Jaxk Reeves and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medical Care and Patient Education and Counseling.

In The Last Decade

Matthew Perri

61 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Perri United States 18 445 372 342 281 242 64 1.4k
Louis A. Morris United States 18 220 0.5× 148 0.4× 250 0.7× 121 0.4× 345 1.4× 48 1.1k
Caroline A. Gaither United States 26 801 1.8× 370 1.0× 222 0.6× 188 0.7× 769 3.2× 87 1.9k
David H. Kreling United States 17 561 1.3× 379 1.0× 180 0.5× 183 0.7× 378 1.6× 73 1.2k
Shane P. Desselle United States 22 695 1.6× 182 0.5× 149 0.4× 103 0.4× 604 2.5× 158 1.8k
Sujit S. Sansgiry United States 20 213 0.5× 151 0.4× 118 0.3× 85 0.3× 278 1.1× 138 1.3k
Jack E. Fincham United States 18 338 0.8× 227 0.6× 61 0.2× 169 0.6× 276 1.1× 87 1.3k
David A. Mott United States 24 1.0k 2.3× 530 1.4× 246 0.7× 288 1.0× 831 3.4× 119 2.2k
Afonso Cavaco Portugal 20 377 0.8× 152 0.4× 106 0.3× 171 0.6× 511 2.1× 114 1.5k
Stephanie Y. Crawford United States 21 260 0.6× 140 0.4× 47 0.1× 127 0.5× 198 0.8× 76 1.1k
Anandi V. Law United States 22 534 1.2× 208 0.6× 67 0.2× 229 0.8× 411 1.7× 75 1.6k

Countries citing papers authored by Matthew Perri

Since Specialization
Citations

This map shows the geographic impact of Matthew Perri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Perri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Perri more than expected).

Fields of papers citing papers by Matthew Perri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Perri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Perri. The network helps show where Matthew Perri may publish in the future.

Co-authorship network of co-authors of Matthew Perri

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Perri. A scholar is included among the top collaborators of Matthew Perri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Perri. Matthew Perri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perri, Matthew, et al.. (2021). Impact of drug utilization management policy on prescription opioid use in Georgia Medicaid. Journal of Pharmaceutical Health Services Research. 12(2). 188–193. 1 indexed citations
2.
Jayawardhana, Jayani, Amanda J. Abraham, Henry N. Young, & Matthew Perri. (2018). Opioids in Georgia Medicaid: gender and insurance disparities in utilization and potential inappropriate prescribing practices. Journal of Pharmaceutical Health Services Research. 9(2). 101–108. 6 indexed citations
3.
Wang, Yu & Matthew Perri. (2018). A Systematic Review of Patient-Reported Satisfaction with Oral Medication Therapy in Patients with Type 2 Diabetes. Value in Health. 21(11). 1346–1353. 8 indexed citations
4.
Perri, Matthew, et al.. (2016). Impact of Animated Spokes-Characters in Print Direct-to-Consumer Prescription Drug Advertising: An Elaboration Likelihood Model Approach. Health Communication. 32(4). 391–400. 20 indexed citations
5.
Perri, Matthew, et al.. (2014). Direct-to-Consumer Advertising of Predictive Genetic Tests: A Health Belief Model Based Examination of Consumer Response. Health Marketing Quarterly. 31(3). 263–278. 9 indexed citations
6.
Sattler, Elisabeth Lilian Pia, Jung Sun Lee, & Matthew Perri. (2013). Medication (Re)fill Adherence Measures Derived from Pharmacy Claims Data in Older Americans: A Review of the Literature. Drugs & Aging. 30(6). 383–399. 115 indexed citations
7.
Menon, Ajit M., et al.. (2012). Impact of Celebrity Pitch in Direct-to-Consumer Advertising of Prescription Drugs. Health Marketing Quarterly. 29(1). 35–48. 14 indexed citations
8.
King, Karen Whitehill, et al.. (2011). Nonbranded or Branded Direct-to-Consumer Prescription Drug Advertising—Which is More Effective?. Health Marketing Quarterly. 28(1). 86–98. 12 indexed citations
9.
Fu, Alex Z., et al.. (2007). Potentially Inappropriate Medication Use and Healthcare Expenditures in the US Community-Dwelling Elderly. Medical Care. 45(5). 472–476. 133 indexed citations
10.
Wade, William E., et al.. (2007). Outcomes of a Medicare Part D education program. Journal of the American Pharmacists Association. 47(3). 382–384. 1 indexed citations
11.
Perri, Matthew. (2006). Communication Skills for Pharmacists. American Journal of Pharmaceutical Education. 70(1). 5 indexed citations
12.
Wade, William E., et al.. (2000). Formulary Management of Low Molecular Weight Heparins. PharmacoEconomics. 17(1). 1–12. 10 indexed citations
13.
Perri, Matthew, et al.. (1999). The past, present, and future of direct-to-consumer prescription drug advertising. Clinical Therapeutics. 21(10). 1798–1811. 34 indexed citations
14.
Perri, Matthew. (1996). Managing Pharmacy Care. American Journal of Pharmaceutical Education. 60(2). 208–212. 1 indexed citations
15.
Perri, Matthew, et al.. (1995). OBRA '90: The Impact on Pharmacists and Patients. American Pharmacy. 35(2). 24–28. 28 indexed citations
16.
Perri, Matthew. (1995). Eight Steps Toward Payment for Cognitive Services. American Pharmacy. 35(9). 20–24. 4 indexed citations
17.
Perri, Matthew, et al.. (1990). Georgia Consumers' Awareness and Perceptions 33 of Generic Drugs After the Scandals. American Pharmacy. 30(10). 33–36. 4 indexed citations
18.
Perri, Matthew. (1989). An Experimental Intervention. Journal of Pharmaceutical Marketing & Management. 3(4). 21–36. 10 indexed citations
19.
Perri, Matthew & W. Michael Dickson. (1987). Direct to Consumer Prescription Drug Advertising. Journal of Pharmaceutical Marketing & Management. 2(1). 3–25. 1 indexed citations
20.
Perri, Matthew, et al.. (1987). Estimating demand for health information: pharmacy counseling services.. PubMed. 7(4). 33–40. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026